Chronic kidney disease in gout in a managed care setting (Q33980619)

30 July 2017

Chronic kidney disease in gout in a managed care setting (English)

1 reference

chronic renal insufficiency

30 July 2017

1 reference

Mahesh J Fuldeore

1

1 reference

30 July 2017

Aylin A Riedel

2

1 reference

30 July 2017

Victoria Zarotsky

3

1 reference

30 July 2017

Bhavik J Pandya

4

1 reference

30 July 2017

Omar Dabbous

5

1 reference

30 July 2017

Eswar Krishnan

6

1 reference

30 July 2017

3 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

12

1 reference

30 July 2017

36

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-12-36

30 July 2017

0 references

cites work

Association of incident gout and mortality in dialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Hyperuricaemia--where nephrology meets rheumatology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Uric acid and incident kidney disease in the community

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Prevalence of chronic kidney disease in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Validity of gout diagnoses in administrative data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Gout in renal transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

New insights into gout epidemiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Gout: epidemiology and lifestyle choices.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

A survey of indications, results and complications of surgery for tophaceous gout

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Relation between adverse events associated with allopurinol and renal function in patients with gout

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Comorbidity measures for use with administrative data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Allopurinol treatment and its effect on renal function in gout: a controlled study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Preliminary criteria for the classification of the acute arthritis of primary gout

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Dietary risk factors for rheumatic diseases

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-12-36

Relationship of uric acid with progression of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-12-36

Appropriate dosing regimen of allopurinol in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-12-36

Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-12-36

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-12-36

Gout in ambulatory care settings in the United States

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174872

Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts

29 October 2018

1 reference

12 December 2020

The optimal use of allopurinol: an audit of allopurinol use in South Auckland

1 reference

12 December 2020

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

1 reference

12 December 2020

Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982

1 reference

12 December 2020

Gout due to renal disease

1 reference

12 December 2020

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout

1 reference

12 December 2020

Hyperuricemia and gout following pediatric renal transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-12-36

1 reference

Dimensions Publication ID

30 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-12-36

9 September 2019

1 reference

30 July 2017

1 reference